Actavis Inc.

NYS : ACT
Pharmaceuticals
Parsippany NJ
IW Best50N/A
2012 Revenue (US$ Millions)$5,915
2011 Revenue (US$ Millions)$4,584
Revenue Growth (%)29.02%
Net Income (US$ Millions)$97
Common Shares Outstanding (Millions)$128
Earnings Per Share (US$)$0.76
Total Equity (US$ Millions)$3,834
Profit Growth (%)-62.71
Profit Margin (%)1.64%
Return On Equity (%)2.73%
Long Term Debt (US$ Millions)$6,257
Debt To Equity Ratio (%)1.63%
Market Capitalization (US$ Millions)$10,982
Total Assets (US$ Millions)$14,104
Return on Assets (%)1.45
Current Assets (US$ Millions)$3,880
Inventories (US$ Millions)$1,543
Current Liabilities (US$ Millions)$2,711
Cost of Goods Sold (US$ Millions)$3,390
Asset Turnover0.42
Inventory Turnover2.79